Protagonist Therapeutics Inc buy SVB Leerink LLC
Start price
19.03.26
/
50%
€88.00
Target price
19.03.27
€95.74
Performance (%)
35.23%
Price
04.08.26
€119.00
Summary
This prediction is currently active. With a performance of 35.23% the BUY prediction by SVB_Leerink_LLC is a big success. This prediction currently runs until 19.03.27. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Protagonist Therapeutics Inc | -1.653% | -1.653% |
| iShares Core DAX® | 2.334% | 1.011% |
| iShares Nasdaq 100 | 1.370% | -3.612% |
| iShares Nikkei 225® | 2.437% | -7.461% |
| iShares S&P 500 | 1.259% | 0.677% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics (PTGX) had its price target raised by Leerink Partners from $107.00 to $110.00. They now have an "outperform" rating on the stock.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by SVB_Leerink_LLC for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€53.00
12.09.25
12.09.25
€62.24
12.09.26
12.09.26
124.53%
04.08.26
04.08.26
